rs1060502859
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_000388.4(CASR):c.2889G>A(p.Lys963Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_000388.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASR | ENST00000639785.2 | c.2889G>A | p.Lys963Lys | synonymous_variant | Exon 7 of 7 | 1 | NM_000388.4 | ENSP00000491584.2 | ||
CASR | ENST00000498619.4 | c.2919G>A | p.Lys973Lys | synonymous_variant | Exon 7 of 7 | 1 | ENSP00000420194.1 | |||
CASR | ENST00000638421.1 | c.2889G>A | p.Lys963Lys | synonymous_variant | Exon 7 of 7 | 5 | ENSP00000492190.1 | |||
CASR | ENST00000490131.7 | c.2658G>A | p.Lys886Lys | synonymous_variant | Exon 5 of 5 | 5 | ENSP00000418685.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 71
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Nephrolithiasis/nephrocalcinosis Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.